
Breast Cancer State of the Science Summit
Duke Cancer Institute faculty provided insight into the exciting breast cancer research being conducted here, in interviews during the 2019 OncLive State of the Science Summit on Breast Cancer last month in Durham.
- Duke Cancer Institute Faculty Describe Latest Efforts in Breast Cancer Research Features Kelly Marcom, MD; Carey Anders, MD; Susan Dent, MD; Jeremy Force, DO; Gretchen G. Kimmick, MD, MS; Sarah Sammons, MD; Kelly Westbrook, MD
- CDK4/6 Inhibitors Continue to Change Practice in HR+ Breast Cancer
Sarah Sammons, MD
- WATCH: Dr. Marcom on Liquid Biopsies in Breast Cancer
Features Kelly Marcom, MD
- Genomics Are Key to Unlocking Breast Cancer Biology
Features Kelly Marcom, MD
- WATCH: Dr. Westbrook on Combatting Tumor Heterogeneity in HER2+ Breast Cancer Features Kelly Westbrook, MD
- WATCH: Dr. Anders Discusses the Use of Neratinib/Capecitabine for HER2-Positive Brain Metastases
Features Carey Anders, MD
- WATCH: Dr. Anders on Sequencing Strategies in the Setting of HER2+ Brain Metastases
Features Carey Anders, MD
- Broader Trial Eligibility Criteria Expands Options for Brain Mets in Breast Cancer
Features Carey Anders, MD
- Expert Emphasizes Exercise to Minimize Cardiac Toxicity in Breast Cancer
Features Susan Dent, MD
- Immunotherapy Begins New Therapeutic Path in Metastatic TNBC
Features Jeremy Force, DO
Other News
WATCH: ESMO 2019 | Cell-Free DNA for GI therapy personalization (VJ Oncology)
Features John Strickler, MD
Inflammatory Breast Cancer Has Diagnostic Challenges, Requires More Awareness (OncLive)
Features Duke Cancer Center
WATCH: Novel Agents Are Changing the Prostate Cancer Treatment Landscape (OncLive)
Features Daniel George, MD
WATCH: Dr. George on Investigational Agents Downstream of the Androgen Receptor in Prostate Cancer (OncLive)
Features Daniel George, MD
WATCH: Dr. Zhang on the IMvigor130 Trial in Metastatic Urothelial Cancer (OncLive)
Features Tian Zhang, MD
Open-Minded Research for Therapeutic Options Needed in TGCT (OncLive)
Features William Eward, MD, DVM
Dr. George on the Use of Radium-223 in Prostate Cancer (OncLive)
Features Daniel George, MD
The Perilous Power of the Preacher’s Wife (New York Times)
Kate Bowler, PhD
Duke wins $5 million grant to help scientists identify environmental contaminants (Raleigh News & Observers)
Features Heather S. Stapleton, PhD
$5 Million Grant Will Fund New Laboratory for Environmental Analysis (Nicholas School of the Environment)
Features Heather S. Stapleton, PhD
Blue Devil of the Week: Searching for Answers in the Genetic Code (Duke Today)
Features Sue Jinks-Robertson, PhD
Letter: Faculty urge Duke to ban vaping (The Chronicle)
Features Sven-Eric Jordt, PhD and Cynthia E Kuhn
Curing Pediatric Cancer in Tanzania: Kristin Schroeder Breaks Through Barriers to Help Families (SOM Magnify)
Features Kristin Schroeder, MD, MPH
Editor's Note: "I'm Not Done with Life Yet" (Duke Today)
Features Duke patient
Papers
Clinical and pathological stage discordance among 433,514 breast cancer patients. American Journal of Surgery. October 2019. Jennifer K. Plichta, Samantha M. Thomas, Amanda R. Sergesketter, Rachel A. Greenup, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Nina Tamirisa, Terry Hyslop, Shelley Hwang.
Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma. Annals of Surgical Oncology. October 2019. M. J. Thornton, H. V. Williamson, K. E. Westbrook, R. A. Greenup, J. K. Plichta, L. H. Rosenberger, A. M. Gupta, T. Hyslop, E. S. Hwang, O. M. Fayanju.
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. Cancer. Aug. 27, 2019. Laura J. Havrilesky, MD, MHSc; Jui‐Chen Yang, MEM; Paula S. Lee, MD, MPH; Angeles Alvarez Secord, MD, MHSc; Jessie A. Ehrisman, BS; Brittany Davidson, MD; Andrew Berchuck, MD; Kathleen M. Darcy, PhD; G. Larry Maxwell, MD; Shelby D. Reed, PhD.
Breast Cancer Awareness Month

Will We Ever Cure Breast Cancer?
Donald McDonnell, PhD, weighs in: